Tag Archives: Merck

New York Pharma Forum: Together We Stand

By Ben Comer | Published: December 13, 2012
Participants in the 23rd Annual NYPF General Assembly last Friday outlined the many challenges facing industry, and the importance of collaboration as a way to move forward.
Posted in Biotech, Events, People, R&D, Strategy, Technology, leadership | Also tagged , , , , , , , , , , | Leave a comment

Pipeline Report Preview

By Reid Paul | Published: November 14, 2012
Posted in Advertising, Biotech, Europe, FDA, Gene therapy, Global, IP, R&D, Regulatory, Strategy, Video | Also tagged , , , , , , , , | Leave a comment

Pharma Throws Greece Another Lifeline. Will Greece Reciprocate?

By Julian Upton | Published: November 14, 2012
Greece took its part on Wednesday in the latest widespread strikes against austerity measures that swept across Europe, throwing travel networks into disarray and sparking violent clashes between police and workers. But for once Greece wasn’t at the forefront of the misery as the country has been thrown a couple more lifelines — not least [...]
Posted in Europe, Global | Also tagged , , , , | Leave a comment

Merck and Novartis Down in Q3 Financial Reports

By Guest Blogger | Published: October 31, 2012
By Jennifer Markarian Pharmaceutical industry leaders Novartis and Merck—among others—released second-quarter 2012 results showing global sales down in third-quarter 2012, with growth in key pharmaceutical products helping to offset losses due to patent expirations.
Posted in Deals, Global, Guest Blog, leadership | Also tagged , , , | Leave a comment

Diabetes Drug Launch 2012: Tip-tops and Promo-flops

By Clark Herman | Published: October 12, 2012
With Halloween candy flooding the shelves in pharmacies across the nation, it’s only appropriate that we turn the conversation toward an ever-growing drug market and therapeutic area: diabetes.
Posted in Advertising, E-Media, FDA, Marketing, Meetings, Strategy | Also tagged , , , , | 1 Comment